학술논문

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial
Document Type
Article
Source
In The Lancet 2-8 August 2014 384(9941):414-426
Subject
Primary Research
Articles
Language
ISSN
0140-6736